Clozapine represents the first significant advance in the pharmacotherapy of schizophrenia since development of phenothiazine antipsychotic drugs in the 1950s and 60s, yet only about 10% of potential patients nationwide are taking the medication.

Download full-text PDF

Source

Publication Analysis

Top Keywords

clozapine promise
4
promise schizophrenia
4
schizophrenia treatment
4
treatment clozapine
4
clozapine represents
4
represents advance
4
advance pharmacotherapy
4
pharmacotherapy schizophrenia
4
schizophrenia development
4
development phenothiazine
4

Similar Publications

Catatonia is one of the most severe psychiatric syndromes, and clinical symptoms and etiology are very heterogeneous. When accompanied by autonomic instability and hyperthermia it’s termed malignant catatonia, which left untreated is associated with significant morbidity and mortality. First-line treatment is high dose benzodiazepines, followed by electroconvulsive therapy (ECT), in case of non-response.

View Article and Find Full Text PDF

Modulation of neural activity is a promising strategy to influence the growth of axons and improve behavioral recovery after damage to the central nervous system. The benefits of neuromodulation likely depend on optimization across multiple input parameters. Here we used a chemogenetic approach to achieve continuous, long-term elevation of neural activity in murine corticospinal tract (CST) neurons.

View Article and Find Full Text PDF

Chronic olanzapine treatment leads to increased opioid receptor expression and changes in feeding regulating neurons in the female rat hypothalamus.

Psychoneuroendocrinology

January 2025

Core Centre for Molecular Morphology, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.

Article Synopsis
  • * The study involved female rats treated with olanzapine, revealing immediate increases in eating (hyperphagia) and continued weight gain, alongside specific changes in opioid receptor expression in the hypothalamus.
  • * Findings suggest that chronic olanzapine leads to increased expression of certain opioid receptors in areas of the hypothalamus linked to appetite regulation, supporting the use of opioid receptor antagonists to counteract olanzapine's negative metabolic effects.
View Article and Find Full Text PDF

The increasing demand in healthcare for accessible and cost-effective analytical tools is driving the development of reliable platforms to the customization of therapy according to individual patient drug serum levels, of anti-psychotics in schizophrenia. A modifier-free microfluidic paper-based electroanalytical device (μPED) holds promise as a portable, sensitive, and affordable solution. While many studies focus on the working electrode catalysts, improvements by engineering aspects of the electrode arrangement are less reported.

View Article and Find Full Text PDF
Article Synopsis
  • India issued its first National Essential Diagnostics List in 2019 to enhance affordable healthcare by improving access and reducing costs for patients.
  • In 2024, the Indian Council of Medical Research is seeking feedback for updating this list.
  • The article advocates for adding Therapeutic Drug Monitoring (TDM) for specific psychotropic medications at district hospitals, supported by recent evidence highlighting its benefits in treatment management.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!